Artículos por temáticas

The late positive potential, emotion and apathy in Parkinson's disease.

Dietz J, Bradley MM, Jones J, Okun MS, Perlstein WM, Bowers D.

Neuropsychologia. 2013 Apr;51(5):960-6. doi: 10.1016/j.neuropsychologia.2013.01.001.

Induction of KLF4 contributes to the neurotoxicity of MPP + in M17 cells: a new implication in Parkinson's disease.

Chen J, Wang X, Yi X, Wang Y, Liu Q, Ge R.

J Mol Neurosci. 2013 Sep;51(1):109-17. doi: 10.1007/s12031-013-9961-3.

White matter abnormalities in Parkinson's disease patients with glucocerebrosidase gene mutations.

Agosta F, Kostic VS, Davidovic K, Kresojević N, Sarro L, Svetel M, Stanković I, Comi G, Klein C, Filippi M.

Mov Disord. 2013 Jun;28(6):772-8. doi: 10.1002/mds.25397.

Emotional and cognitive social processes are impaired in Parkinson's disease and are related to behavioral disorders.

Narme P, Mouras H, Roussel M, Duru C, Krystkowiak P, Godefroy O.

Neuropsychology. 2013 Mar;27(2):182-92. doi: 10.1037/a0031522.

Does 123I-MIBG scintigraphy really assist the diagnosis of Parkinson's disease?

Chiaravalloti A, Stefani A, Pierantozzi M, Stanzione P, Schillaci O.

Parkinsonism Relat Disord. 2013 Aug;19(8):772-3. doi: 10.1016/j.parkreldis.2013.04.015. No abstract available.

The beneficial role of thiamine in Parkinson disease.

Luong KV, Nguyễn LT.

CNS Neurosci Ther. 2013 Jul;19(7):461-8. doi: 10.1111/cns.12078. Review.

PACAP protects against salsolinol-induced toxicity in dopaminergic SH-SY5Y cells: implication for Parkinson's disease.

Brown D, Tamas A, Reglödi D, Tizabi Y.

J Mol Neurosci. 2013 Jul;50(3):600-7. doi: 10.1007/s12031-013-0015-7.

Contribution of β-phenethylamine, a component of chocolate and wine, to dopaminergic neurodegeneration: implications for the pathogenesis of Parkinson's disease.

Borah A, Paul R, Mazumder MK, Bhattacharjee N.

Neurosci Bull. 2013 Oct;29(5):655-60. doi: 10.1007/s12264-013-1330-2. Review.

Low-frequency subthalamic nucleus deep brain stimulation for axial symptoms in advanced Parkinson's disease.

Sidiropoulos C, Walsh R, Meaney C, Poon YY, Fallis M, Moro E.

J Neurol. 2013 Sep;260(9):2306-11. doi: 10.1007/s00415-013-6983-2.

Critical involvement of the motor cortex in the pathophysiology and treatment of Parkinson's disease.

Lindenbach D, Bishop C.

Neurosci Biobehav Rev. 2013 Dec;37(10 Pt 2):2737-50. doi: 10.1016/j.neubiorev.2013.09.008. Review.

Some symptoms in early-stage Parkinson's often undertreated.

[No authors listed]

Johns Hopkins Med Lett Health After 50. 2013 Jul;25(5):8. No abstract available.

Multiclass classification of FDG PET scans for the distinction between Parkinson's disease and atypical parkinsonian syndromes.

Garraux G, Phillips C, Schrouff J, Kreisler A, Lemaire C, Degueldre C, Delcour C, Hustinx R, Luxen A, Destée A, Salmon E.

Neuroimage Clin. 2013 Jun 14;2:883-93. doi: 10.1016/j.nicl.2013.06.004.

Effects of hemochromatosis and transferrin gene mutations on peripheral iron dyshomeostasis in mild cognitive impairment and Alzheimer's and Parkinson's diseases.

Mariani S, Ventriglia M, Simonelli I, Spalletta G, Bucossi S, Siotto M, Assogna F, Melgari JM, Vernieri F, Squitti R.

Front Aging Neurosci. 2013 Aug 5;5:37. doi: 10.3389/fnagi.2013.00037.

AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study.

Stocchi F, Rascol O, Destee A, Hattori N, Hauser RA, Lang AE, Poewe W, Stacy M, Tolosa E, Gao H, Nagel J, Merschhemke M, Graf A, Kenney C, Trenkwalder C.

Mov Disord. 2013 Nov;28(13):1838-46. doi: 10.1002/mds.25561.

[DBS therapy for Parkinson's disease - our approach].

Sato S, Takiyama Y, Ogino Y, Watanabe K, Terao T, Matsumoto C, Chiken S, Nambu A, Nishiyama K, Kumabe T, Fujii K.

Rinsho Shinkeigaku. 2013;53(11):1053-5. Review. Japanese.